EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitSystematische Übersicht

Safety and efficacy of current active transcutaneous bone conduction implants: a systematic review

Meghna Ray, Muhammad Suleiman iD, Solomon Pudi, Vicki Proctor, Axel Kaehne, Jaydip Ray

European Archives of Oto-Rhino-Laryngology · 14.11.2026

DOI: 10.1007/s00405-026-10763-2 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift European Archives of Oto-Rhino-Laryngology, online erschienen am 14.11.2026. Verfasst von Meghna Ray und 5 weiteren Autor:innen. Beteiligte Einrichtung: ENT Department, Sheffield Teaching Hospitals, (Royal Hallamshire Hospital) Glossop Road, Sheffield, S10 2TB, UK. Die Arbeit nennt 77 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

PURPOSE: This is the first systematic review comparing all currently available active transcutaneous bone conduction implants (atBCI) (Bonebridge®, Osia®, and Sentio®) with intermediate-term data on their safety and efficacy. METHODS: PubMed, EMBASE, Mendeley, and Google Scholar were searched between 01 January 2012 and 03 April 2026. The Preferred Reporting Items for Systematic Reviews and Meta-analyses (PRISMA) protocol and Cochrane guidance were followed. Included were randomised control trials (RCTs), case-control, cohort studies and case series. Articles were screened by two reviewers with senior author oversight. RESULTS: Of the 776 papers identified, 66 met the inclusion criteria after deduplication and were included in the final study. The studies covered 1918 patients who had had atBCI. There was significant heterogeneity in assessment and outcome measures, as well as the timing of tests. Fifty-three studies reported functional hearing gain. Nine studies provided sufficient quantitative data, including measures of variance, to permit random-effects meta-analysis. The pooled functional hearing gain was 34.0 dB HL (95% CI 30.9-37.0 dB HL). Only 15 studies reported improvements in Speech Reception Threshold (ranging 10.81 to 42). Complications rates were very low. CONCLUSION: The atBCIs available at present appear to provide measurable benefits in hearing rehabilitation for their targeted patient population. Although all currently available active transcutaneous bone conduction implant systems were represented in the quantitative synthesis, the evidence base was dominated by Bonebridge studies. Consequently, the pooled estimate should be interpreted as an overall summary across a heterogeneous body of evidence rather than as evidence of equivalent treatment effects across individual implant systems.

Schlagwörter

Stichwörter der Autor:innen

Bone conduction implantBonebridgeHearing lossOSIASentio

Autor:innen und Institutionen

  • ENT Department, Sheffield Teaching Hospitals, (Royal Hallamshire Hospital) Glossop Road, Sheffield, S10 2TB, UK.
  • ENT Department, Sheffield Teaching Hospitals, (Royal Hallamshire Hospital) Glossop Road, Sheffield, S10 2TB, UK. Muhammad.suleiman@nhs.net.
  • Warrington and Halton Hospitals, Warrington, UK.
  • Medical School, Edge Hill University, St Helens Road, Ormskirk, Lancashire, L39 4QP, UK.

ORCID-Profile: Muhammad Suleiman

Zitieren

APA

Ray, M., Suleiman, M., Pudi, S., Proctor, V., Kaehne, A., & Ray, J. (2026). Safety and efficacy of current active transcutaneous bone conduction implants: a systematic review. European Archives of Oto-Rhino-Laryngology. https://doi.org/10.1007/s00405-026-10763-2

Vancouver

Ray M, Suleiman M, Pudi S, Proctor V, Kaehne A, Ray J. Safety and efficacy of current active transcutaneous bone conduction implants: a systematic review. European Archives of Oto-Rhino-Laryngology. 2026. doi:10.1007/s00405-026-10763-2

BibTeX
@article{Ray2026,
  author = {Ray, Meghna and Suleiman, Muhammad and Pudi, Solomon and Proctor, Vicki and Kaehne, Axel and Ray, Jaydip},
  title = {Safety and efficacy of current active transcutaneous bone conduction implants: a systematic review},
  journal = {European Archives of Oto-Rhino-Laryngology},
  year = {2026},
  doi = {10.1007/s00405-026-10763-2}
}
Kostenlos starten →